Report Code: A12675 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Chlorzoxazone Market
Request Now !Chlorzoxazone is a centrally acting muscle relaxant drug administered in response to acute musculoskeletal syndrome. It is used as a relaxant against strains and sprain caused due to muscle pull, and is administered in combination with analgesics and physical therapy. White crystalline powder color and odorless tablet are the tangent features of the drug. Although chlorzoxazone is regarded as an ideal skeletal muscle relaxant available in the market, it has been seen to cause fatal liver diseases. Some other side effects of the drug include yellow eyes, abdominal bloating, dark skin texture, vomiting, diarrhea, and persistent nausea. Administration of the drug under pregnancy is of major concern due to possible negative reactions that might occur, and thus the drug should be taken only under prescription and proper guidance. The drug is available in various forms in tablets of 250 and 500mg. The brands for chlorzoxazone include Parafon Forte and Lorzone.
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the chlorzoxazone market.
Top Impacting Factors
Key Market Trends
Key Benefits of the Report
Questions Answered in the Chlorzoxazone Report
Chlorzoxazone Market Report Highlights
Aspects | Details |
---|---|
By Application |
|
By Product Type |
|
By Region |
|
Key Market Players | Johnson & Johnson, Intas Pharma Inc., MedPointe Pharmaceuticals, Abbott Laboratories, Merck & Co. Inc., Novartis AG, Hoffman-La Roche Ltd, Galderma S.A., Meda Pharma Inc., Pfizer Inc |
Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers